Several new posters red to do some DE. The company already reported doubling of MOS for 2nd line lung prior to a coding error by a 3rd party. It seems more and more likely they will be able to salvage the data in some form. Also, it appears based on what many of the science guys on this board say, that they may be a couple of months from finding out that they have doubled the MOS for 1st line lung and pancreatic. Owning pphm is still a gamble but what is it worth if it shows Bavi doubles the MOS in 1st Line lung, 2nd line lung and pancreatic? Who knows but it isn't $5 or $10 a share.
News 
Market Data 
Discover 
